ArticleBiological research2026
Smarce1-dependent modulation of Stat3 signaling governs cardiomyocyte proliferation.
Article in Biological research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Developmental pathways that govern organ growth during embryogenesis are often reactivated in adult organisms to support tissue regeneration. Despite their profound clinical relevance for cardiac repair, the molecular mechanisms underlying heart growth during development and regeneration remain incompletely understood. Here, we identify Smarce1, a core subunit of the SWI/SNF chromatin-remodeling complex, as a key regulator of cardiomyocyte (CM) proliferation in zebrafish. Using genetically engineered Smarce1 loss-of-function models, we combined heart-specific transcriptomic (RNA-seq, single-cell RNA-seq) and epigenomic (ATAC-seq) profiling to delineate Smarce1-dependent regulatory networks. Smarce1 deficiency enhanced CM proliferative activity by modulating cell cycle dynamics and chromatin accessibility. Integrative analyses revealed that Smarce1 regulates the transcriptional landscape of Stat3 signaling components, thereby linking chromatin remodeling to proliferative signaling. Genetic and pharmacological modulation of Stat3 signaling confirmed its functional contribution to Smarce1-dependent CM proliferation, establishing a conserved Smarce1-Stat3 axis operating during both developmental and adult cardiac growth. Collectively, our findings uncover an epigenetic mechanism by which Smarce1 fine-tunes CM proliferation and identify Smarce1 as a promising target for promoting regenerative CM expansion.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.